SUNNYVALE, Calif., Oct. 10, 2019 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2019 on Tuesday, October 29, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.
The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International). In addition, a dial up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 855-859-2056 (USA), or 404-537-3406 (International), Conference ID: 4191278.
A live webcast of the call will also be available from the Investor Relations section of the Company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the second quarter of fiscal 2020.
About Accuray
Accuray Incorporated (Nasdaq: ARAY) develops, manufactures and sells radiotherapy systems that are intended to make cancer treatments shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives. Our radiation treatment delivery systems in combination with fully-integrated software solutions set the industry standard for precision and cover the full range of radiation therapy and radiosurgery procedures. For more information, please visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter and YouTube.
Contacts:
Investor Contacts:
Michael Polyviou
EVC Group LLC
732-933-2754
mpolyviou@evcgroup.com
Media Contacts:
Beth Kaplan
Accuray Inc
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/accuray-to-report-fiscal-2020-first-quarter-financial-results-on-october-29-2019-300936793.html
SOURCE Accuray Incorporated
Toronto, Ontario--(Newsfile Corp. - June 13, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or…
– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2…
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard®…
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - June 13, 2025) - Izotropic Corporation (CSE:…
This designation enables Glassbeam to support federal government agency customers increase uptime for all MRI…
CAMBRIDGE, Mass. and LIVERPOOL, United Kingdom, June 13, 2025 /PRNewswire/ -- XtalPi, a leading life…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="117px" width="400px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
